general prnewswire_all 5/22/2026 0 views

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Issued on behalf of Conexeu Sciences Inc. Companies mentioned: Conexeu Sciences Inc. (NASDAQ: CNXU), Integra LifeSciences Holdings Corporation (NASDAQ: IART), Evolus, Inc. (NASDAQ: EOLS), Bioventus Inc. (NASDAQ: BVS), Mesoblast Limited (NASDAQ: MESO) KEY TAKEAWAYS A fresh Nasdaq debut....
Relevant beings: precast.in
View original →